“…infections include pyelonephritis, peritonitis, arthritis, abscesses, endovascular infections, pneumonia, and meningitis, with associated high mortality rates 2,4,6,8,11,22 . Notably, many infections have been described in hosts with hypogammaglobulinemia from administration of rituximab, 1,4,5,23 rather than transplant recipients. While the exact pathophysiology is unclear, hypogammaglobulinemic patients appear to be more susceptible to colonization of mucous membranes, especially of the urogenital tract, and progression to invasive disease 23 …”